Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported annual fiscal-period values; no daily interpolation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
-27.13x
EV/EBIT RATIO AVG 3Y
-28.45x
EV/EBIT RATIO AVG 5Y
-29.28x
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$7.31B
EV/EBIT Ratio
464.07x
TTM Avg
360.08x
3Y Avg
139.42x
5Y Avg
139.42x
Market Cap
$8.50B
EV/EBIT Ratio
39.03x
TTM Avg
38.74x
3Y Avg
33.04x
5Y Avg
33.11x
Market Cap
$6.27B
EV/EBIT Ratio
234.40x
TTM Avg
117.63x
3Y Avg
154.90x
5Y Avg
154.90x
Market Cap
$9.74B
EV/EBIT Ratio
18.07x
TTM Avg
15.99x
3Y Avg
16.46x
5Y Avg
15.53x
Market Cap
$9.75B
EV/EBIT Ratio
7.16x
TTM Avg
8.98x
3Y Avg
11.50x
5Y Avg
11.72x
Market Cap
$10.31B
EV/EBIT Ratio
30.75x
TTM Avg
9.48x
3Y Avg
10.43x
5Y Avg
11.98x
Market Cap
$10.37B
EV/EBIT Ratio
N/A
TTM Avg
25.59x
3Y Avg
34.39x
5Y Avg
25.01x
Market Cap
$10.91B
EV/EBIT Ratio
29.44x
TTM Avg
59.10x
3Y Avg
38.81x
5Y Avg
34.74x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $7.47B | N/A | -27.13x | -28.45x | -29.28x |
| Oscar Health, Inc. (OSCR)vs › | $7.31B | 464.07x | 360.08x | 139.42x | 139.42x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.50B | 39.03x | 38.74x | 33.04x | 33.11x |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.27B | 234.40x | 117.63x | 154.90x | 154.90x |
| Henry Schein, Inc. (HSIC)vs › | $9.74B | 18.07x | 15.99x | 16.46x | 15.53x |
| Universal Health Services, Inc. (UHS)vs › | $9.75B | 7.16x | 8.98x | 11.50x | 11.72x |
| Molina Healthcare, Inc. (MOH)vs › | $10.31B | 30.75x | 9.48x | 10.43x | 11.98x |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | N/A | 25.59x | 34.39x | 25.01x |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.91B | 29.44x | 59.10x | 38.81x | 34.74x |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 73.61x | 77.38x | 58.19x | 58.47x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2025-12-31 | -46.15x |
| 2024-12-31 | -8.10x |
| 2023-12-31 | -33.29x |
| 2022-12-31 | -26.25x |
| 2021-12-31 | -27.90x |
| 2020-12-31 | -33.99x |
| 2019-12-31 | -52.12x |
